Howard Schwartz > DLA Piper LLP (US) > Baltimore, United States > Lawyer Profile
DLA Piper LLP (US) Offices

100 LIGHT STREET
BALTIMORE, MD 21209-3600
MARYLAND
United States
- Firm Profile
- Go to...
Howard Schwartz

Work Department
Corporate; Mergers and Acquisitions; Emerging Growth and Venture Capital; Capital Markets; Intellectual Property and Technology; Regulatory and Government Affairs; Life Sciences; Healthcare
Position
Partner, Regional Office Head for Baltimore Corporate & Securities Group
Career
Howard Schwartz structures and negotiates mergers and acquisitions, complex collaborations, joint ventures, and financings for clients ranging from multinational bio-pharmaceutical and device companies to start-up biotechs. Additionally, he advises boards of directors and significant shareholders on disclosure issues, corporate communications policies, and fiduciary duty matters. His clients and deal experience extend throughout the United States, Europe and Asia as well to emerging markets and include all segments of the industry – pharma, biotech, medtech, diagnostics, animal health, vaccines and health services.
In addition, Howard regularly represents life sciences companies in their operational matters, such as global supply, distribution, clinical trials, manufacturing, and research and license arrangements between industry and academic institutions.
Languages
English, Russian
Education
J.D., University of Virginia; B.A., Brown University
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > Financial products
- Tax > International tax
- Real estate > Land use/zoning
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Tax > US taxes: contentious
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Insurance > Advice to insurers
- Industry focus > Cannabis
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Finance > Fintech
- Insurance > Insurance: non-contentious
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Media, technology and telecoms > Media and entertainment: transactional
- International trade and national security > National Security
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Media, technology and telecoms > Advertising and marketing: litigation
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Dispute resolution > International litigation
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- International trade and national security > CFIUS
- Finance > Commercial lending > Advice to direct lenders/private credit
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: oil and gas
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Dispute resolution > International arbitration
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Transport > Rail and road: litigation and regulation